(Q33414008)

26 July 2017

6 references

22 June 2019

19 September 2019

2 October 2019

11 September 2020

28 October 2020

19 July 2021

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs (English)

1 reference

biomedical investigative technique

26 July 2017

1 reference

11 September 2020

1 reference

19 September 2019

1 reference

2 October 2019

non-steroidal anti-inflammatory drug

1 reference

28 October 2020

anti-inflammatory agent

1 reference

19 July 2021

Ebba Holme Hansen

2

0 references

author name string

Lise Aagaard

series ordinal

1

1 reference

26 July 2017

3 March 2009

7 references

BMC Clinical Pharmacology

26 July 2017

22 June 2019

19 September 2019

2 October 2019

11 September 2020

28 October 2020

19 July 2021

7 references

26 July 2017

22 June 2019

19 September 2019

2 October 2019

11 September 2020

28 October 2020

19 July 2021

9

1 reference

26 July 2017

4

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

6 references

22 June 2019

19 September 2019

2 October 2019

11 September 2020

28 October 2020

https://scigraph.springernature.com/pub.10.1186/1472-6904-9-4

19 July 2021

0 references

0 references

cites work

Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Systematic reviews of adverse effects: framework for a structured approach

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Antidepressants and risk of upper gastrointestinal bleeding

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Safety of doxycycline and minocycline: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Application of a propensity score to adjust for channelling bias with NSAIDs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

A population-based cohort study of mortality among users of ibuprofen in Denmark

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Stevens-Johnson syndrome associated with ciprofloxacin: A review of adverse cutaneous events reported in Sweden as associated with this drug

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Adverse Drug Events Involving COX-2 Inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Quantitative methods in pharmacovigilance: focus on signal detection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Renal failure associated with the use of celecoxib and rofecoxib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Antimicrobial-induced mania (antibiomania): a review of spontaneous reports

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

COMT inhibitors and liver toxicity.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

The link between sunshine and phototoxicity of sparfloxacin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

21 June 2018

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Hemorrhage and thrombocytopenia caused by selective serotonin uptake inhibitors (SSRI)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Visual field defects due to antiepileptic drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Tiaprofenic acid and severe cystitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Non-puerperal lactation associated with antidepressant drug use

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Liver reactions to oral low-dose tetracyclines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Peripheral sensory disturbances related to treatment with fluoroquinolones

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Cholestatic hepatitis associated with flucloxacillin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Vioxx, the implosion of Merck, and aftershocks at the FDA.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Quality of life as a predictor for change in disability in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Creating knowledge about adverse drug reactions: a critical analysis of the Danish reporting system from 1968 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

A population-based case-control teratologic study of oral erythromycin treatment during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Pemphigus variant associated with penicillin use: a case-cohort study of 363 patients from Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Glucose homeostasis abnormalities associated with use of gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Steroids and risk of upper gastrointestinal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Nimesulide and renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Ocular adverse effects associated with cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Fluoxetine treatment and testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Reports of withdrawal syndrome with the use of SSRIs: a case/non-case study in the French Pharmacovigilance database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Effects of first-trimester fluoxetine exposure on the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Serotonin syndrome induced by fluvoxamine and mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-9-4

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

A population based historical cohort study of the mortality associated with nabumetone, Arthrotec, diclofenac, and naproxen

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Selective serotonin uptake inhibitors and pancreatitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Flucloxacillin and cholestatic hepatitis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656469

Erythromycin-associated cholestatic hepatitis

31 October 2018

1 reference

12 December 2020

Clarithromycin--a precipitant for acute psychotic stress

1 reference

12 December 2020

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

12 December 2020

Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy

1 reference

12 December 2020

Drug-induced cholestatic hepatitis from common antibiotics

1 reference

12 December 2020

Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Technology assessment of pharmaceuticals. The necessity of user perspective

1 reference

12 December 2020

Premature closure of the fetal ductus arteriosus after maternal use of non-steroidal anti-inflammatory drugs. Adverse Drug Reactions Advisory Committee

1 reference

12 December 2020

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

1 reference

12 December 2020

Prescription-event monitoring of 10,401 patients treated with fluvoxamine

1 reference

12 December 2020

Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics

1 reference

12 December 2020

Fluoroquinolone-induced tendinopathy: also occurring with levofloxacin

1 reference

12 December 2020

Technology assessment in a user perspective--experiences with drug technology

1 reference

12 December 2020

Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use

1 reference

12 December 2020

Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database

1 reference

12 December 2020

Pulmonary thromboendarterectomy--risk factors for early survival and hemodynamic improvement

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6904-9-4

1 reference

PubMed ID

19254390

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6904-9-4

9 September 2019

1 reference

26 July 2017

1 reference

PubMed ID

19254390